CAS 72629-94-8: Perfluorotridecanoic acid

Perfluorotridecanoic acid is an organic compound that belongs to the group of perfluoroalkanes. It is a colorless liquid with a mild odor. Perfluorotridecanoic acid is used as a solvent in analytical methods, such as gas chromatography and high-performance liquid chromatography. In addition, it has been shown to have anti-inflammatory properties and may be used in the treatment of allergic symptoms. The most common route of exposure to this compound is through inhalation or ingestion, although it can also be absorbed through the skin or eyes. The following are some potential descriptions for the product: Rifapentine Rifapentine is an anti-tuberculosis drug that belongs to the class of rifamycins. It is the most active of the rifamycins for the treatment of tuberculosis. Rifapentine inhibits bacterial growth by binding to DNA-dependent RNA polymerase, thereby

Pentacosafluorotridecanoic Acid (PFTrDA) is a perfluoroalkyl substance (PFAS) that exhibits various biological impacts across different species. In zebrafish embryos, exposure to PFTrDA induces yolk sac edema and increases mRNA expression of thyroid hormone synthesis genes, including tshβ, at concentrations of 0.1 and 0.3 mg/L. At a dosage of 10 mg/kg, PFTrDA reduces serum testosterone and luteinizing hormone levels, as well as palmitic acid, linoleic acid, and oleic acid levels in the testicular interstitial cells of late adolescent rats. In humans, maternal plasma levels of PFTrDA during pregnancy are positively correlated with the development of eczema in female infants (but not male infants), and PFTrDA levels are higher in the livers of cancerous humans compared to non-cancerous ones. Additionally, PFTrDA is found in marine mammals.